FDA Clearance Tracker · P030006-S013
PROLIEVE THERMODILATATION SYSTEM
Last checked: Nov 20, 2026Latest source record: Nov 20, 2007 (this decision)Source: openFDAMethods & limitations
Decided
Nov 20, 2007
Approved
Time to decision
211 days
Received Apr 23, 2007. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P030006-S013
- Device name
- PROLIEVE THERMODILATATION SYSTEM
- Applicant
- Medifocus, Inc.
- Applicant location
- Columbia, MD
- Received
- Apr 23, 2007
- Decided
- Nov 20, 2007
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P030006
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
APPROVAL OF THE POST-APPROVAL STUDY.
Source documents
Other decisions for Medifocus, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.